Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
In a landmark Phase 2 trial published in the New England Journal of Medicine, participants receiving the 12 mg dose experienced mean weight loss of 24.2% at 48 weeks, significantly exceeding results from earlier GLP-1 or dual-agonist therapies
Journal: J Neurosci Res
Lets say youve been on a higher dose, and it took you five months to build up to that dose
Sleep 9 , 151161 (2017)
Future work should also focus on other outcomes important to patients like MASLD/MASH, arthritis, sleep apnea, and others
US$ 28.65
US$ 26.12
US$ 27.81
US$ 26.27
US$ 26.52
US$ 26.60
US$ 24.01
